European Commission’s antitrust inquiry results in case against Servier and generics firms
This article was originally published in SRA
Executive Summary
The European Commission has opened its first antitrust case following the inquiry into competition in the pharmaceutical sector1,2. The case involves a settlement agreement between the French firm Servier and a number of generic companies.